Tracleer

In the US, Tracleer (bosentan systemic) is a member of the drug class agents for pulmonary hypertension and is used to treat Pulmonary Arterial Hypertension.

US matches:

• Tracleer

UK matches:

• Tracleer (bosentan) 125mg film-coated tablets
• Tracleer (bosentan) 62.5mg film-coated tablets
• Tracleer (bosentan) 125mg film-coated tablets (SPC)
• Tracleer (bosentan) 62.5mg film-coated tablets (SPC)

Ingredient matches for Tracleer

Bosentan

Bosentan is reported as an ingredient of Tracleer in the following countries:

• Denmark


• Germany


• Slovenia


• Taiwan


• Thailand


• Turkey

Bosentan monohydrate (a derivative of Bosentan) is reported as an ingredient of Tracleer in the following countries:

• Australia


• Austria


• Belgium


• Canada


• Czech Republic


• Finland


• France


• Hungary


• Iceland


• Ireland


• Israel


• Italy


• Japan


• Luxembourg


• Netherlands


• New Zealand


• Norway


• Singapore


• Slovakia


• Spain


• Sweden


• Switzerland


• United Kingdom


• United States

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.